Scientists think that combining navitoclax with ruxolitinib may help people with myelofibrosis. In this demo 50 % the people have navitoclax and ruxolitinib. The opposite 50 percent have ruxolitinib and also a dummy drug (placebo ). No utilization of any AbbVie trademark, trade title, or trade gown in This page https://vonj655vgq7.wikigiogio.com/user